Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ZEVRA THERAPEUTICS, INC.
| Metric | ZEVRA THERAPEUTICS, INC. ZVRAHealthcare |
|---|---|
| Quality Score | 54 / 100 |
| Revenue (latest) | $106M |
| Net income (latest) | $83M |
| Operating margin | −59.1% |
| Net margin | 78.2% |
| Return on equity | 53.8% |
| Return on assets | 29.2% |
| Return on capital (ROCE) | −25.6% |
| Debt / equity | 0.84× |
| Revenue growth (YoY) | 350.9% |
| Altman Z″ (distress) | -0.84 |
| Accruals / assets | 29.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.